Improving outcomes in acute and chronic periprosthetic hip and knee joint infection with a multidisciplinary approach.

PJI infected arthroplasty multidisciplinary team revision surgery

Journal

Bone & joint open
ISSN: 2633-1462
Titre abrégé: Bone Jt Open
Pays: England
ID NLM: 101770336

Informations de publication

Date de publication:
Jul 2021
Historique:
entrez: 12 7 2021
pubmed: 13 7 2021
medline: 13 7 2021
Statut: ppublish

Résumé

Periprosthetic hip and knee infection remains one of the most severe complications following arthroplasty, with an incidence between 0.5% to 1%. This study compares the outcomes of revision surgery for periprosthetic joint infection (PJI) following hip and knee arthroplasty prior to and after implementation of a specialist PJI multidisciplinary team (MDT). Data was retrospectively analyzed from a single centre. In all, 29 consecutive joints prior to the implementation of an infection MDT in November 2016 were compared with 29 consecutive joints subsequent to the MDT conception. All individuals who underwent a debridement antibiotics and implant retention (DAIR) procedure, a one-stage revision, or a two-stage revision for an acute or chronic PJI in this time period were included. The definition of successfully treated PJI was based on the Delphi international multidisciplinary consensus. There were no statistically significant differences in patient demographics or comorbidities between the groups. There was also no significant difference in length of overall hospital stay (p = 0.530). The time taken for formal microbiology advice was significantly shorter in the post MDT group (p = 0.0001). There was a significant difference in failure rates between the two groups (p = 0.001), with 12 individuals (41.38%) pre-MDT requiring further revision surgery compared with one individual (6.67%) post-MDT inception. Our standardized multidisciplinary approach for periprosthetic knee and hip joint infection shows a significant reduction in failure rates following revision surgery. Following implementation of our MDT, our success rate in treating PJI is 96.55%, higher than what current literature suggests. We advocate the role of a specialist infection MDT in the management of patients with a PJI to allow an individualized patient-centred approach and care plan, thereby reducing postoperative complications and failure rates. Cite this article:

Identifiants

pubmed: 34247508
doi: 10.1302/2633-1462.27.BJO-2021-0064.R1
pmc: PMC8325970
doi:

Types de publication

Journal Article

Langues

eng

Pagination

509-514

Références

J Bone Joint Surg Am. 2013 Dec 18;95(24):2177-84
pubmed: 24352771
Ann R Coll Surg Engl. 2004 Jul;86(4):267-71
pubmed: 15239869
Bone Joint J. 2021 Jan;103-B(1):18-25
pubmed: 33380199
J Arthroplasty. 2019 Feb;34(2S):S339-S350
pubmed: 30348566
J Arthroplasty. 2010 Jan;25(1):87-92
pubmed: 19056210
Bone Joint J. 2019 Feb;101-B(2):132-139
pubmed: 30700114
J Orthop Surg Res. 2019 Mar 13;14(1):78
pubmed: 30866970
J Bone Jt Infect. 2020 Apr 27;5(3):137-144
pubmed: 32566453
J Arthroplasty. 2020 Mar;35(3S):S24-S30
pubmed: 32046827
Bone Joint Res. 2019 Dec 3;8(11):570-572
pubmed: 31832177
Bone Joint J. 2013 Nov;95-B(11):1450-2
pubmed: 24151261
Orthopedics. 2008 Jun;31(6):581-8; quiz 589-90
pubmed: 18661881
Knee. 2020 Dec;27(6):1857-1865
pubmed: 33202289
Bone Joint J. 2014 Oct;96-B(10):1312-8
pubmed: 25274914
Arch Orthop Trauma Surg. 2019 Apr;139(4):467-473
pubmed: 30488282
ScientificWorldJournal. 2013 May 28;2013:821650
pubmed: 23781163
J Bone Joint Surg Am. 2007 Oct;89 Suppl 3:144-51
pubmed: 17908880
J Arthroplasty. 2017 Jul;32(7):2047-2050
pubmed: 28343826
Clin Orthop Relat Res. 2013 Feb;471(2):510-8
pubmed: 22983683
PLoS One. 2016 Mar 11;11(3):e0151537
pubmed: 26967645
J Bone Joint Surg Am. 2016 Aug 3;98(15):1313-9
pubmed: 27489323
J Arthroplasty. 2017 Feb;32(2):526-531
pubmed: 27646832
Knee Surg Sports Traumatol Arthrosc. 2019 Apr;27(4):1011-1017
pubmed: 30850881
J Bone Joint Surg Am. 2019 Jan 2;101(1):74-84
pubmed: 30601418
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
Knee. 2016 Aug;23(4):736-9
pubmed: 27225442
Bone Joint J. 2015 Aug;97-B(8):1076-81
pubmed: 26224824
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
pubmed: 17403800
BMC Infect Dis. 2016 Oct 10;16(1):553
pubmed: 27724919
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
J Bone Joint Surg Am. 2019 Jun 19;101(12):1061-1069
pubmed: 31220022
N Engl J Med. 2019 Jan 31;380(5):425-436
pubmed: 30699315
Clin Orthop Relat Res. 2017 Jul;475(7):1891-1900
pubmed: 28389865
Biomed Res Int. 2015;2015:345475
pubmed: 26064901
Arthroplast Today. 2020 Jun 12;6(3):360-362
pubmed: 32566717
SICOT J. 2019;5:5
pubmed: 30816089
Am J Orthop (Belle Mead NJ). 1999 Mar;28(3):161-5
pubmed: 10195839
Bone Joint J. 2015 Feb;97-B(2):197-201
pubmed: 25628282
Clin Orthop Relat Res. 2011 Nov;469(11):2992-4
pubmed: 21938532

Auteurs

Mairiosa Biddle (M)

Queen Elizabeth University Hospital, Glasgow, UK.

John W Kennedy (JW)

Queen Elizabeth University Hospital, Glasgow, UK.

Pauline M Wright (PM)

Queen Elizabeth University Hospital, Glasgow, UK.

Neil D Ritchie (ND)

Queen Elizabeth University Hospital, Glasgow, UK.

R M D Meek (RMD)

Queen Elizabeth University Hospital, Glasgow, UK.

Brian P Rooney (BP)

Queen Elizabeth University Hospital, Glasgow, UK.

Classifications MeSH